GlycoMimetics Highlights Preclinical Data Showing Role of E-selectin Ligands in Multiple Myeloma
GlycoMimetics Highlights Preclinical Data Showing Role of E-selectin Ligands in Multiple Myeloma
About this item
Full title
GlycoMimetics Highlights Preclinical Data Showing Role of E-selectin Ligands in Multiple Myeloma
Publisher
Jacksonville: Close-Up Media, Inc
Journal title
Health & Beauty Close - Up, 2017
Language
English
Formats
Publication information
Publisher
Jacksonville: Close-Up Media, Inc
Subjects
More information
Scope and Contents
Contents
According to a media release, E-selectin ligands are recognized by an antibody known as HECA452. "The results in this preclinical study demonstrate that targeting E-selectin may provide a novel approach to treatment of patients with multiple myeloma and could potentially restore sensitivity to chemotherapy and, in particular, proteasome inhibitor t...
Alternative Titles
Full title
GlycoMimetics Highlights Preclinical Data Showing Role of E-selectin Ligands in Multiple Myeloma
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1895652095
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1895652095
How to access this item
Log in as a Library member
